Stock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration

Stock Track04-27 09:35

QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.

The healthcare company revealed that its self-developed AI evidence-based medicine agent product "Zheng Yuanfang" has been officially integrated into the group's platform "Yilu Qingsong," which provides professional services for doctors and medical professionals. This development achieves a product-level integration of the company's medical AI capabilities with its proprietary doctor service network.

"Zheng Yuanfang" is described as an evidence-based medicine agent designed around evidence-based methodology, customized for real clinical scenarios. The product provides doctors with explainable, verifiable, and traceable medical decision support, effectively elevating AI from a "medical Q&A tool" to an "evidence-based decision assistant." This advancement in the company's AI healthcare offerings appears to have driven investor optimism during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123403210?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 09:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123403210","market":"hk","top_or_hot":-1,"title":"Stock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration","media":"Stock Track","content":"<p>QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.</p><p>The healthcare company revealed that its self-developed AI evidence-based medicine agent product \"Zheng Yuanfang\" has been officially integrated into the group's platform \"Yilu Qingsong,\" which provides professional services for doctors and medical professionals. This development achieves a product-level integration of the company's medical AI capabilities with its proprietary doctor service network.</p><p>\"Zheng Yuanfang\" is described as an evidence-based medicine agent designed around evidence-based methodology, customized for real clinical scenarios. The product provides doctors with explainable, verifiable, and traceable medical decision support, effectively elevating AI from a \"medical Q&A tool\" to an \"evidence-based decision assistant.\" This advancement in the company's AI healthcare offerings appears to have driven investor optimism during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-27 09:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.</p><p>The healthcare company revealed that its self-developed AI evidence-based medicine agent product \"Zheng Yuanfang\" has been officially integrated into the group's platform \"Yilu Qingsong,\" which provides professional services for doctors and medical professionals. This development achieves a product-level integration of the company's medical AI capabilities with its proprietary doctor service network.</p><p>\"Zheng Yuanfang\" is described as an evidence-based medicine agent designed around evidence-based methodology, customized for real clinical scenarios. The product provides doctors with explainable, verifiable, and traceable medical decision support, effectively elevating AI from a \"medical Q&A tool\" to an \"evidence-based decision assistant.\" This advancement in the company's AI healthcare offerings appears to have driven investor optimism during the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1123403210","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123403210","pubTimestamp":1777253701,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.The healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02661":"轻松健康"},"translate_title":"个股赛道|青松健康盘中大涨5.67%借力AI医疗产品整合","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1},"content_text":"QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.The healthcare company revealed that its self-developed AI evidence-based medicine agent product \"Zheng Yuanfang\" has been officially integrated into the group's platform \"Yilu Qingsong,\" which provides professional services for doctors and medical professionals. This development achieves a product-level integration of the company's medical AI capabilities with its proprietary doctor service network.\"Zheng Yuanfang\" is described as an evidence-based medicine agent designed around evidence-based methodology, customized for real clinical scenarios. The product provides doctors with explainable, verifiable, and traceable medical decision support, effectively elevating AI from a \"medical Q&A tool\" to an \"evidence-based decision assistant.\" This advancement in the company's AI healthcare offerings appears to have driven investor optimism during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123403210","isCrawlerRequest":true}